Industry

DUBLIN–(BUSINESS WIRE)–The “microRNA (miRNA) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global microRNA (miRNA) Market to Reach $485.3 Million by 2026 Key drivers propelling growth in the global microRNA market include greater awareness, increasing emphasis on R&D activities, growth of advanced and well-organized technology, rising government initiatives globally, escalating … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Respiratory Inhalers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Respiratory Inhalers Market to Reach $48.7 Billion by 2026 Respiratory care market occupies a significant presence in the medical field, as respiratory dysfunction is among the most widespread healthcare problem globally. Growth drivers include increasing incidence of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global In Silico Clinical Trials Market, By Industry (Medical Devices v/s Pharmaceuticals), By Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases, Orthopedic, Dermatology, Others), By Region, Competition Forecast and Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The Global in Silico Clinical Trials Market was valued to be USD2743.64 million in the year … [Read more…]

NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren Lui, CEO and Executive Director of Aptorum Group will present both in-person and virtually at the H.C. Wainwright … [Read more…]

MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Morgan Stanley 20th Annual Global Healthcare Conference at the Grand Hyatt in New York on September 12, 2022, at 9:20 … [Read more…]

VANCOUVER, B.C.–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today reported financial results and provided a corporate update for the second quarter ended June 30, 2022. “The Company released … [Read more…]

CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-25 after the close of trading on the Nasdaq Stock Market on Friday, August 26, 2022. Athersys … [Read more…]

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:35 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be … [Read more…]

Humana Medicare Advantage members will have access to P3 Nevada’s Primary Care Providers in Clark and Nye Counties HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) and Humana, a leading health and well-being company, have signed an … [Read more…]

SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced that it will host an Investor Day on September 20, 2022 at 1:00 p.m. Eastern Time. The Investor Day will provide an opportunity for investors and analysts to hear from members of … [Read more…]